Hanania NA - Search Results

1

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.

Hanania NA, Noonan M, Corren J, Korenblat P, Zheng Y, Fischer SK, Cheu M, Putnam WS, Murray E, Scheerens H, Holweg CT, Maciuca R, Gray S, Doyle R, McClintock D, Olsson J, Matthews JG, Yen K. Hanania NA, et al. Thorax. 2015 Aug;70(8):748-56. doi: 10.1136/thoraxjnl-2014-206719. Epub 2015 May 22. Thorax. 2015. PMID: 26001563 Free PMC article. Clinical Trial.

2

Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W. Hanania NA, et al. Ann Intern Med. 2011 May 3;154(9):573-82. doi: 10.7326/0003-4819-154-9-201105030-00002. Ann Intern Med. 2011. PMID: 21536936 Free article. Clinical Trial.

3

Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma.

Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G; AIR2 Trial Study Group. Castro M, et al. Among authors: hanania na. Ann Allergy Asthma Immunol. 2011 Jul;107(1):65-70. doi: 10.1016/j.anai.2011.03.005. Epub 2011 Apr 14. Ann Allergy Asthma Immunol. 2011. PMID: 21704887

4

Lebrikizumab treatment in adults with asthma.

Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG. Corren J, et al. Among authors: hanania na. N Engl J Med. 2011 Sep 22;365(12):1088-98. doi: 10.1056/NEJMoa1106469. Epub 2011 Aug 3. N Engl J Med. 2011. PMID: 21812663 Free article. Clinical Trial.

5

Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.

Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE. Hanania NA, et al. Respir Med. 2012 Jan;106(1):91-101. doi: 10.1016/j.rmed.2011.09.002. Epub 2011 Oct 29. Respir Med. 2012. PMID: 22040533 Free article. Clinical Trial.

6

Targeting IgE in asthma.

Kuhl K, Hanania NA. Kuhl K, et al. Among authors: hanania na. Curr Opin Pulm Med. 2012 Jan;18(1):1-5. doi: 10.1097/MCP.0b013e32834deebb. Curr Opin Pulm Med. 2012. PMID: 22139745 Review.

7

The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.

Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann B. Hanania NA, et al. Chest. 2012 Jul;142(1):119-127. doi: 10.1378/chest.11-2231. Chest. 2012. PMID: 22241764 Clinical Trial.

8

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, Lal P, Arron JR, Harris JM, Busse W. Hanania NA, et al. Am J Respir Crit Care Med. 2013 Apr 15;187(8):804-11. doi: 10.1164/rccm.201208-1414OC. Am J Respir Crit Care Med. 2013. PMID: 23471469 Clinical Trial.

9

Antifungals in severe asthma.

Parulekar AD, Diamant Z, Hanania NA. Parulekar AD, et al. Among authors: hanania na. Curr Opin Pulm Med. 2015 Jan;21(1):48-54. doi: 10.1097/MCP.0000000000000117. Curr Opin Pulm Med. 2015. PMID: 25415408 Review.

10

One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD.

Donohue JF, Hanania NA, Make B, Miles MC, Mahler DA, Curry L, Tosiello R, Wheeler A, Tashkin DP. Donohue JF, et al. Among authors: hanania na. Chest. 2014 Dec;146(6):1531-1542. doi: 10.1378/chest.14-0117. Chest. 2014. PMID: 25451347 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters